[go: up one dir, main page]

SE7613426L - MIXED ESTERS OF POLYOLES - Google Patents

MIXED ESTERS OF POLYOLES

Info

Publication number
SE7613426L
SE7613426L SE7613426A SE7613426A SE7613426L SE 7613426 L SE7613426 L SE 7613426L SE 7613426 A SE7613426 A SE 7613426A SE 7613426 A SE7613426 A SE 7613426A SE 7613426 L SE7613426 L SE 7613426L
Authority
SE
Sweden
Prior art keywords
polyoles
mixed esters
acyl group
acyl
groups
Prior art date
Application number
SE7613426A
Other languages
Swedish (sv)
Inventor
P Bauder
J-P Ricard
A Schulthess
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH17376A external-priority patent/CH616911A5/fr
Priority claimed from CH979076A external-priority patent/CH617175A5/en
Application filed by Om Lab Sa filed Critical Om Lab Sa
Publication of SE7613426L publication Critical patent/SE7613426L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00Esters of sulfuric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

of the disclosure Therapeutically active compounds of the general formula: (F) wherein Ac1 is a first acyl group, Ac2 is a second acyl group different from Ac1, A is a C-C bond or a divalent organic residue; R1, R2 are a hydrogen atom or a lower alkyl group, R1 and R2 together being able to take part in the formation of a ring having up to 6 atoms, A, R1 and R2 may be substituted by -OH groups esterified or not by acyl groups. These compounds have a hypolipemient and hypocholesterolemient action, and inhibit the aggregation of blood platelets.
SE7613426A 1976-01-08 1976-11-30 MIXED ESTERS OF POLYOLES SE7613426L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH17376A CH616911A5 (en) 1976-01-08 1976-01-08
CH979076A CH617175A5 (en) 1976-07-30 1976-07-30 Processes for the preparation of mixed polyol esters

Publications (1)

Publication Number Publication Date
SE7613426L true SE7613426L (en) 1977-07-09

Family

ID=25683750

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613426A SE7613426L (en) 1976-01-08 1976-11-30 MIXED ESTERS OF POLYOLES

Country Status (18)

Country Link
JP (1) JPS5285139A (en)
BG (1) BG27537A3 (en)
CA (1) CA1075708A (en)
DD (1) DD128400A5 (en)
DE (1) DE2654951A1 (en)
EG (1) EG12290A (en)
ES (1) ES453795A1 (en)
FI (1) FI763529A (en)
FR (1) FR2337552A1 (en)
GB (1) GB1572035A (en)
GR (1) GR61818B (en)
IL (1) IL51039A0 (en)
NL (1) NL7613457A (en)
PL (1) PL117246B1 (en)
PT (1) PT65894B (en)
RO (1) RO70355A (en)
SE (1) SE7613426L (en)
YU (1) YU286476A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL176551C (en) * 1979-04-25 1985-05-01 Shell Int Research PROCESS FOR PREPARING AN AROMATIC HYDROCARBON MIXTURE BY CATALYTIC CONVERSION OF A MIXTURE OF CARBON MONOXIDE AND HYDROGEN.

Also Published As

Publication number Publication date
JPS5285139A (en) 1977-07-15
DD128400A5 (en) 1977-11-16
EG12290A (en) 1979-06-30
NL7613457A (en) 1977-07-12
FR2337552A1 (en) 1977-08-05
PL117246B1 (en) 1981-07-31
PL194851A1 (en) 1979-05-07
FI763529A (en) 1977-07-09
BG27537A3 (en) 1979-11-12
YU286476A (en) 1982-08-31
PT65894B (en) 1978-05-18
GB1572035A (en) 1980-07-23
IL51039A0 (en) 1977-02-28
GR61818B (en) 1979-01-22
DE2654951A1 (en) 1977-07-21
RO70355A (en) 1981-08-17
CA1075708A (en) 1980-04-15
PT65894A (en) 1976-12-01
ES453795A1 (en) 1978-01-16

Similar Documents

Publication Publication Date Title
GB862548A (en) Improvements in or relating to phytocidal compositions of matter
IE42812L (en) Polymer adhesive composition
ES431514A1 (en) 2-Heteroaryl-methyl)-5,9{62 -dialkyl-6,7-benzomorphans and salts thereof
DE3587596D1 (en) Pyridazinone derivatives, their production and use.
ES431057A1 (en) N-{8 (Methoxymethyl-furyl)-methyl{9 -morphinans or -6,7-benzomorphans and salts thereof
ES405983A1 (en) N-fluoroalkylated phenylethylamine
ES432613A1 (en) O-Alkyl-S-alkyl-O-{8 2-substituted-pyrimidin(4)yl{9 thionothiolphosphoric acid esters
SE7613426L (en) MIXED ESTERS OF POLYOLES
ES465176A1 (en) Novel compound having pharmacological activity* method for their production* intermediate compound useful for their production and medical compositions containing same
ES427115A1 (en) Novel benzoylphenylacetic acid derivatives
ATE29024T1 (en) BICYCLOOCTANE DERIVATIVES, THEIR PRODUCTION AND USE.
GB1345301A (en) Hydroxy-py ridone-monosulphonic acids
ES374154A1 (en) Certain benzimidazole as rodenticides
SE7714210L (en) ANTIRINOVIRUS MEDICINE
ES449718A1 (en) Insecticidal and acaricidal O-ethyl-O-{8 1,6-dihydro-1-substituted-6-oxo-pyridazin(3)yl{9 -thionobenzenephosphonic acid esters
IE44449L (en) Morphanthridines
FR2366258A1 (en) PLANT PROTECTION AGENTS, THEIR ACTIVE CONSTITUENTS AND METHOD FOR PREPARING THEIR
ES8302718A1 (en) Derivatives of 7-beta-(ketoximinoacylamido)-ceph-3-em-4-carboxylic acids, process for their preparation and their pharmaceutical compositions containing them.
JPS5535100A (en) Clavuranic acid derivative*its composition and manufacture
ES483236A1 (en) Pyrazolidine-dione derivatives and their preparation and use in therapy
GB1445409A (en) Alpha-phenyl-fatty acid compounds and pharmaceutical compo sitions containing them
IE41906L (en) But-2-enoanilides
ES432562A1 (en) O,S-Dialkyl-O-(2-cyanophenyl)-thionothiolphosphoric acid esters and insecticidal and acaricidal compositions and method
ES409336A1 (en) The preparation of new phenylphormamidines. (Machine-translation by Google Translate, not legally binding)
GB1322919A (en) Manufacture of 3-acyl-or 3-alkoxycarbonyl-5,6-dihydro-4h-pyrans

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7613426-1

Format of ref document f/p: F